Belgium recently introduced the regulatory framework for an attractive new real estate investment vehicle, the specialized real estate investment fund (gespecialiseerd vastgoedbeleggingsfonds (GVBF) / fonds d’investissement immobilier spécialisé (FIIS)) (SREIF).
Belgium startup Teamleader, which began life while co-founders Jeroen De Wit, Willem Delbare and Mathias De Loore were studying together at university, has raised €10 million in Series B funding. The round is led by previous backer Fortino Capital.
Edinburgh tidal developer Nova Innovation, in partnership with Belgium based green energy company Elsa, have deployed the first 100kW turbine as part of the 500kW tidal power project off the Shetland Islands, Scotland.
Riding the coattails of a ‘small pieces, loosely joined’ approach to the enterprise, Belgium startup PieSync offers a platform that connects a plethora of cloud applications and syncs contacts stored in those apps two-way. That’s no mean feat considering the risk of data corruption or overwriting an important contact’s information, which is why, says PieSync, companies are warming to the company’s proposition. VCs appear to like the product, too, seeing PieSync raise $1.6 million in new funding. The round is being led by Ark Angels Activator Fund and SOFI (PMV). The startup had previous raised a small amount of...
Investors will commit a minimum of €48bn to global real estate this year, according to research by INREV, ANREV and PREA.
Milwaukee’s small life sciences scene doesn’t usually grab the attention of big venture capital firms, so it’s perhaps surprising that a recent event attracted investors from the likes of Novartis and OrbiMed.
Belgian power utility Electrabel said Saturday it had restarted a nuclear reactor at its ageing Tihange plant, just days after being forced to shut it down following a fire in the electricity supply system.
Accenture was selected by Atrias to build, deploy and manage a single clearing house application for Belgian energy sector players.
GamaMabs Pharma has raised €15 million ($16.4 million) to advance a monoclonal antibody against gynecological cancers into the clinic and up to proof-of-concept. Edmond de Rothschild Investment Partners' BioDiscovery 4 came on board to lead the Series B round.
The crisis gripping Britain's steel industry has forced one of the nation's oldest industrial firms to consider selling out to China as cheap Chinese metal and rising energy prices threaten its existence.